Skip to Content

PO BOX 683148 | Houston, TX 77268 | ph 888-247-8700 | fx 888-247-8706

NPTA is the largest professional society for pharmacy technicians. Membership is open to pharmacy technicians, students, and educators. more...

12-Feb-14 9:00 AM  CST  

FDA Looking Into Risk of Possible Cardiovascular Events Associated with Low T Products 

Recent research suggests that one in four men suffer from low testosterone levels.  In addition, the number of men with low T is expected to reach at least 6.5 million in the next 12 years according to Genesis Health Institute. 

            Some of the symptoms of low T are hair loss, loss of muscle mass, loss of interest in sex, and depressed mood.  Due to these symptoms some men seek treatment for low T.  Currently, the FDA is looking into the possible risk of cardiovascular events associated with low T treatment products.  The risks may include stroke, heart attack, and possible death associated with low T treatments approved by the FDA.  The FDA has not found that these low T pharmaceuticals increase the risk of cardiovascular events, but is asking patients to report adverse events and side-effects to the MedWatch Safety Information and Adverse Event Reporting program. 

            Some causes of low T are aging, primary gonad disease, congenital diseases, acquired causes, and secondary hypogonadism of the pituitary or hypothalamus.  With low T therapies the ultimate goal is to return hormone levels back to normal. 



1.  FDA Safety Announcement.  “FDA Evaluating Risk of Stroke, Heart Attack, and Death With FDA-Approved Testosterone Products.”  FDA.  Web.  Date of Access:  9 Feb 2014. 


2.  Harding, Anne.  “13 Surprising Facts About Testosterone.”  Web.  Date of Access:  9 Feb 2014. 


3.  “Is It Low Testosterone?”  Genesis Health Institute.  Web.  Date of Access:  9 Feb 2014. 



  • Currently 1/5

Rating: 1.00 / 5.00  - Not feeling it
1 ratings


Post a Comment

0 / 500 characters

Add to Favorites


For additional information on this Article article, please contact:

Jennifer O'Reilly

Source: Jennifer S. O’Reilly for NPTA

Related Documents:

Content Tags:


Other Recent Articles:

Return to Pharmacy Technician Articles Search

NPTA is lobbying for pharmacy technician issues, conducting industry-related research, developing benchmark reports, manage a national... more

NPTA is the #1 source for pharmacy technician products.


Are you Prepared? Chemotherapy Certification course